Organisation paid for research Program year 2025 Source: CMS Open Payments

Behavioral Research Specialists, LLC

Neither a doctor nor a teaching hospital

Research payments

$381,527

35 payments

Through program year 2025, Behavioral Research Specialists, LLC is reported as receiving $381,527 in research payments, across 35 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$30,652	1
2021	Research	$177,237	16
2020	Research	$66,357	11
2019	Research	$107,281	7

Breakdown

Who paid Research payments · program years 2019–2025

Avanir Pharmaceuticals, Inc. $148,588 19 payments
Merck Sharp & Dohme Corporation $142,614 8 payments
Corcept Therapeutics $59,674 7 payments
E.R. Squibb & Sons, L.L.C. $30,652 1 payment

Studies the money was for Research payments · program years 2019–2025

A Phase 2B Randomized, Double-Blind, Placebo- and Active-Controlled Trial of the Efficacy and Safety of MK-8189 in Participants Experiencing an Acute Episode of Schizophrenia $83,594 4 payments
Cort118335-877 $59,674 7 payments
15-Avp-786-303 $52,720 7 payments
18-Avp-786-207 $49,130 7 payments
15-Avp-786-302 $46,737 5 payments
A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of suvorexant MK-4305 for the Treatment of Sleep Disturbance in Patients with Alzheimer s Disease $46,238 1 payment
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in De Novo Subjects With DSM-5 Schizophrenia $30,652 1 payment
A Phase 2B Randomized, Double-Blind, Placebo- and Active-Controlled Trial of the Efficacy and Safety of MK-8189 in Participants Experiencing an Acute Episode of Schizophrenia $12,782 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.